U.S. Physical Therapy Future Growth
Future criteria checks 4/6
U.S. Physical Therapy is forecast to grow earnings and revenue by 30.8% and 9.7% per annum respectively. EPS is expected to grow by 37.8% per annum. Return on equity is forecast to be 9.8% in 3 years.
Key information
30.8%
Earnings growth rate
37.8%
EPS growth rate
Healthcare earnings growth | 19.0% |
Revenue growth rate | 9.7% |
Future return on equity | 9.8% |
Analyst coverage | Good |
Last updated | 16 Dec 2024 |
Recent future growth updates
Recent updates
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
Jan 03Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
Nov 09U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
Aug 07U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
Jul 17U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
Jun 04There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
May 21U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
May 11Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
May 05A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Apr 21Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
Apr 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
Mar 04The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
Dec 23Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
Dec 07U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Oct 13Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
Oct 13U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital
Sep 05Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Aug 15Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?
Aug 01U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
Jul 19At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
May 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 16U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet
Apr 01Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Mar 04U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 23U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit
Feb 12Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?
Jan 24We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
Dec 20Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching
Dec 05U.S. Physical Therapy: Not The Most Comfortable Prospect
Nov 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 794 | 48 | 87 | 92 | 4 |
12/31/2025 | 735 | 57 | 71 | 86 | 7 |
12/31/2024 | 664 | 45 | 66 | 79 | 7 |
9/30/2024 | 639 | 14 | 73 | 82 | N/A |
6/30/2024 | 621 | 16 | 68 | 77 | N/A |
3/31/2024 | 606 | 18 | 66 | 75 | N/A |
12/31/2023 | 599 | 18 | 73 | 82 | N/A |
9/30/2023 | 585 | 24 | 64 | 72 | N/A |
6/30/2023 | 575 | 26 | 62 | 70 | N/A |
3/31/2023 | 564 | 28 | 50 | 58 | N/A |
12/31/2022 | 548 | 29 | 50 | 59 | N/A |
9/30/2022 | 536 | 39 | 48 | 57 | N/A |
6/30/2022 | 522 | 38 | 59 | 68 | N/A |
3/31/2022 | 509 | 37 | 61 | 70 | N/A |
12/31/2021 | 490 | 31 | 68 | 76 | N/A |
9/30/2021 | 477 | 31 | 78 | 86 | N/A |
6/30/2021 | 461 | 30 | 81 | 87 | N/A |
3/31/2021 | 418 | 32 | 95 | 101 | N/A |
12/31/2020 | 418 | 32 | 92 | 100 | N/A |
9/30/2020 | 423 | 30 | 82 | 91 | N/A |
6/30/2020 | 431 | 31 | 72 | 82 | N/A |
3/31/2020 | 473 | 29 | 55 | 65 | N/A |
12/31/2019 | 477 | 31 | 52 | 62 | N/A |
9/30/2019 | 472 | 30 | 56 | 65 | N/A |
6/30/2019 | 468 | 23 | 62 | 71 | N/A |
3/31/2019 | 457 | 18 | 63 | 71 | N/A |
12/31/2018 | 449 | 17 | 66 | 73 | N/A |
9/30/2018 | 442 | 18 | 63 | 70 | N/A |
6/30/2018 | 432 | 22 | N/A | 65 | N/A |
3/31/2018 | 421 | 21 | N/A | 58 | N/A |
12/31/2017 | 410 | 22 | N/A | 57 | N/A |
9/30/2017 | 392 | 20 | N/A | 53 | N/A |
6/30/2017 | 377 | 20 | N/A | 42 | N/A |
3/31/2017 | 363 | 21 | N/A | 51 | N/A |
12/31/2016 | 353 | 21 | N/A | 51 | N/A |
9/30/2016 | 348 | 20 | N/A | 48 | N/A |
6/30/2016 | 344 | 21 | N/A | 49 | N/A |
3/31/2016 | 337 | 21 | N/A | 49 | N/A |
12/31/2015 | 327 | 21 | N/A | 38 | N/A |
9/30/2015 | 320 | 21 | N/A | 45 | N/A |
6/30/2015 | 313 | 20 | N/A | 43 | N/A |
3/31/2015 | 308 | 20 | N/A | 45 | N/A |
12/31/2014 | 301 | 19 | N/A | 41 | N/A |
9/30/2014 | 290 | 19 | N/A | 45 | N/A |
6/30/2014 | 278 | 18 | N/A | 45 | N/A |
3/31/2014 | 267 | 18 | N/A | 44 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: USPH's forecast earnings growth (30.8% per year) is above the savings rate (2.6%).
Earnings vs Market: USPH's earnings (30.8% per year) are forecast to grow faster than the US market (15% per year).
High Growth Earnings: USPH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: USPH's revenue (9.7% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: USPH's revenue (9.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: USPH's Return on Equity is forecast to be low in 3 years time (9.8%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/07 01:17 |
End of Day Share Price | 2025/01/07 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
U.S. Physical Therapy, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Petusky | Barrington Research Associates, Inc. |
Alexander Paris | Barrington Research Associates, Inc. |
Joanna Sylvia Gajuk | BofA Global Research |